Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer

Table 1

Characteristics of patients included in the study.

Characteristic	No. of patients	Percent of total patients (%)
Median of age (range)	46 (35–82)
Menopausal status (pre/post)	11/10	52,4/47,6
Estradiol Receptor
Negative	5	23,8
Positive	9	42,9
Unknown	7	33,3
HER 2 Receptor
Negative	13	61,9
Positive	1	4,8
Unknown	7	7
Patients by number of metastatic sites (1/2/>2)	2/11/8	9,5/52,4/38,1
Metastases localization (𝑛=50)
(i) Lung/Pleura	10	47,6
(ii) Liver	6	28,6
(iii) Skin	7	33,3
(iv) Soft tissue	6	28,6
(v) Bone	12	57,1
(vi) Lymph nodes	5	23,8
(vii) Others	3	14,3